Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
NASDAQ · Healthcare
Amylyx Pharmaceuticals, Inc. Common Stock Total Assets 2021–2025
Amylyx Pharmaceuticals, Inc. Common Stock annual total assets history from 2021 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Amylyx Pharmaceuticals, Inc. Common Stock total assets as of December 31, 2025: 332.6M, a 71.79% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. Common Stock total assets for 2025 were 332.6M, a 71.79% increase from 2024.
- Amylyx Pharmaceuticals, Inc. Common Stock total assets for 2024 were 193.6M, a 62.58% decrease from 2023.
- Amylyx Pharmaceuticals, Inc. Common Stock total assets for 2023 were 517.5M, a 32.19% increase from 2022.
- Amylyx Pharmaceuticals, Inc. Common Stock total assets for 2022 were 391.5M.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amylyx Pharmaceuticals, Inc. Common Stock Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $333 |
| 2024 | $194 |
| 2023 | $517 |
| 2022 | $391 |
| 2021 | $106 |
Amylyx Pharmaceuticals, Inc. Common Stock Total Assets — FAQ
Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) total assets over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMLX's total assets history?
The chart and table above show Amylyx Pharmaceuticals, Inc. Common Stock's total assets by year and by quarter, including the growth rate.